Patent
4 articles
Doctors of the World Opposes the Patent on Sofosbuvir
Hepatitis C: scourge, remedy and scandal
This is the first time in Europe that a medical NGO uses this juridical tool to improve patients access to treatment. More
Hepatitis C: No More Treatment Rationing; Universal Access to Generic Medicines Everywhere!
16 April 2016
People with HCV and their allies from Spain and around the world have gathered at the International Liver Congress to protest the outrageous price of life-saving HCV medicines. More
Hepatitis C: Gilead Patent on Sofosbuvir Partially Maintained Following MdM Patent Opposition
Paris, 5 October 2016
European Patent Office (EPO) has taken its decision following Médecins du Monde (MdM) patent opposition on Gilead’s sofosbuvir. MdM applauds EPO’s decision to revoke partially the patent. More
Sofosbuvir Case in Brazil
Sofosbuvir case in Brazil is well analysed in a new publication ’Access to Medicines and Vaccines: Implementing Flexibilities Under Intellectual Property Law’. More
